Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trial Imprimer Veuillez voter Vote 1 Vote 2 Vote 3 Vote 4 Vote 5 Author:... Read Full Article
